(secondQuint)Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention.

 Randomized, stratified, double-blind, placebo-controlled, parallel-group, multi-center study followed by active-treatment phase.

 Adults with one-year history of episodic migraine and currently, previously or never received migraine prophylactic medication will be randomized to one of two AMG 334 treatment groups or a placebo treatment group during the double blind treatment phase.

 During the active treatment phase, subjects will be randomized to one of the two AMG 334 treatment groups.

.

 Study to Evaluate the Efficacy and Safety of AMG 334 in Migraine Prevention@highlight

Randomized, stratified, double-blind, placebo-controlled, parallel-group, multi-center study followed by active-treatment phase.

 To evaluate the effect of AMG 334 compared to placebo on the change from baseline in monthly migraine days.

